LAV
Venture capitalActively deployingHong Kong · Seed–Series C
Investment thesis
LAV invests in exceptional entrepreneurs developing high-quality, science-based biomedical products with potential to become industry-leading treatments. The firm prioritizes people with demonstrated ambition, experience, leadership, and integrity, providing long-term capital and strategic support including executive recruitment, industry connections, and business development guidance. LAV focuses on companies with products that will address significant disease markets within 5-10 years, guided by rigorous scientific standards and alignment with sustainable healthcare innovation rather than short-term financial speculation.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 7 of 75 portfolio companiesBiotech ×7Medical Devices ×4AI & Machine Learning ×1Digital Health ×1Healthtech ×1
HQs:China×1Germany×1
Investments · showing 60 of 75
founders shown can be your intro pathCullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
BiotechDigital Health
KSQ Therapeutics develops eTIL therapies—engineered tumor-infiltrating lymphocyte treatments for solid tumors—using its proprietary CRISPRomics platform to identify and target novel therapeutic candidates through genome-wide CRISPR/Cas9 functional genomic screens.
AI & Machine LearningBiotechMedical Devices
Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
Biotech
NiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2α, CDK2, and KRAS targets using structure-based drug design.
Biotech
Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples. The company serves research institutions and laboratories conducting genomics and molecular biology research.
BiotechMedical DevicesCologne, DE
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.
BiotechHealthtechMedical Devices
Frequently asked questions
- What stage does LAV invest at?
- LAV invests at the Seed, Series A, Series B, Series C stages.
- What sectors does LAV focus on?
- LAV focuses on Biotech, Healthtech, Medical Devices.
- Where is LAV located?
- LAV is headquartered in Hong Kong, HK.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.